Bromide

Bromide

SCHEMBL4342117

Br.Cc1ccccc1Cn1ccn(CC(=O)c2cc(C(C)(C)C)c(O)c(C(C)(C)C)c2)c1=N

nearest known ligand 0.52

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3APH1AAPH1BCHRM2CHRM3EZH2GRIN2AHTR1AHTR1BHTR1DHTR1FHTR3ANCSTNP2RY12PSEN1PSEN2PSENENSIGMAR1SLC6A2SLC6A3SLC6A4

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
ACHE known ✓ P22303 3/20 0.39
F2R P25116 10/20 0.52
MITF O75030 1/20 0.40
ALDH1A1 P00352 1/20 0.40
LMNA P02545 1/20 0.40
MAPT P10636 1/20 0.40
MAOB P27338 3/20 0.39
MAOA P21397 3/20 0.39
HTT P42858 1/20 0.38
BCHE P06276 2/20 0.38
POLB P06746 1/20 0.36
CYP3A4 P08684 1/20 0.36
HSP90AA1 P07900 1/20 0.36
HSP90B1 P14625 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14346245 0.99 F2R (0.53) F2RMITFALDH1A1LMNAMAPT
Bromide SCHEMBL4340625 0.87 F2R (0.56) F2RALDH1A1LMNAMAOBMAOA
Bromide SCHEMBL4338928 0.86 F2R (0.66) F2RLMNAMAPTMAOBMAOA
SCHEMBL14346226 0.84 F2R (0.67) F2RMAOBMAOAACHEBCHE
Bromide SCHEMBL4338937 0.83 F2R (0.48) F2RALDH1A1MAOBHSP90AA1HSP90B1
SCHEMBL14369538 0.83 F2R (0.43) F2RMAOBMAOAACHEBCHE
Bromide SCHEMBL6752734 0.82 F2R (0.74) F2RMITFALDH1A1LMNAMAPT
Bromide SCHEMBL4352117 0.81 F2R (0.50) F2RMAOBMAOAACHEBCHE
Bromide SCHEMBL4336053 0.81 F2R (0.59) F2RMAOBMAOAACHEBCHE
SCHEMBL14346297 0.79 F2R (0.60) F2RMAOBMAOAACHEBCHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1391456-B1 2-IMINOIMIDAZOLE DERIVATIVES EISAI R&D MAN CO LTD (JP) 2009-07-22 EP disclosed
US-7304083-B2 2-iminoimidazole derivatives (2) EISAI R&D MANAGEMENT CO., LTD. (JP) 2007-12-04 US disclosed
US-20050004197-A1 2-iminoimidazole derivatives (2) EISAI R&D MANAGEMENT CO., LTD. (JP) 2005-01-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050004197-A1 2-iminoimidazole derivatives (2) H1-2, H1-3, H1-4 ACHE 4210/4885F2R 2393/4885MITF 4179/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.